Anxiety disorders have the highest lifetime prevalence of any mental illness worldwide, leading to high societal costs and economic burden. Current pharmacotherapies for worry disorders are associated with adverse effects and low efficacy. Cannabidiol () is a constituent of the plant, which has potential therapeutic prop- erties for various indications. After the recent legalization